INCREASED MAST CELL TRYPTASE DENSITY AND TRANSFORMING GROWTH FACTOR-β1 IN PULMONARY MUSCULAR ARTERIES OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

格日力,小泉知展,本田孝行,山本洋,花岗正幸,久保惠嗣
DOI: https://doi.org/10.3969/j.issn.1006-8252.2002.01.001
2002-01-01
Abstract:Pulmonary hypertension,which is a complication of chronic obstructive pulmonary disease (COPD),is characterized histologically by vascular remodeling.However,the latter is poorly understood from a pathogenic stnadpoint.We previously reported that mast cell tryptase and transforming growth factor-β1(TGF-β1)were highly immunostained around remodeled pulmonary arteries in rats who lived at high altitude,but it whether or not these changes are present in COPD patients is unknown.To clarify this, we performed histological and immunohistochemical studies on the pulmonary artery in 10 patients with severe emphysema who underwent lung volume reduction surgery and 5 nonsmokers with small peripheral lung cancer who underwent lobectomy as controls.Percent wall thickness of pulmonary arteries with external diameters of 100-200μm in COPD patients and controls were 36.0(+-)4.5% and 22.6(+-)3.3%(P<0.05), respectively. The number of tryptase-positive mast cells around vessels and small airways in COPD patients was greatly increased compared to that of the controls (P<0.01), and it was well correlated with wall thickness of vessels (r=0.85,P<0.01).TGF-β1 immunostaining was intense in the neutrophils and mononuclear cells of the lung in COPD patients, whereas it was not detected in controls. These findings suggest that overexpression of mast cell tryptase and TGF-β,which may be caused by chronic airway inflammation hypoxemia and /of hypoxemia,plays an important role in modulating vascular remodeling in the patients with COPD.
What problem does this paper attempt to address?